MAY 20, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Eplerenone (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for labeling changes to generic eplerenone; describes a regulatory action, not clinical evidence of efficacy or safety.
Reported
Approval status date2026-05-20
Dosage strengths approved25 mg, 50 mg